维普中文期刊产品整合服务
8篇 您的检索式:作者名="Schelman WR"
    题名 作者 年代 出处 被引量
1The poly(ADP-ri- bose) polymerase inhibitor niraparib (MK4827) in BRCA muta- tion carriers and patients with sporadic cancer: a phase 1 dose- escalation trial 显示文摘Sandhu SK Schelman WR Wilding G 2013Lancet Oneol2013,14,9:1
2Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the asso- ciated reduction in Bcl-2 expression 显示文摘Schelman WR Andres R Ferguson P 2004J Brain Res Mol Brain Res2004,128,:1
3Angiotensin II attenuatesNMDA receptor-mediated neuronal cell death and prevents the asso-ciated reduction in Bcl-2 expression显示文摘Schelman WR Andres R Ferguson P 2004J Brain Res Mol BrainRes2004,128,:1
4Cytotoxic evaluation of 3-aminopyridine-2-carboxaldehyde thiosemicarba- zone, 3-AP, in peripheral blood lymphocytes of patients with refractory solid tumors using electron paramagnetic resonance 显示文摘Kolesar JM Sachidanandam K Schelman WR 2011Exp TherMed2011,2,1:1
5The poly ( ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial显示文摘SANDHU SK SCHELMAN WR WILDING G 2013Lancet Oneol2013,14,9:1
6Angiotensin type-2 (AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells显示文摘Schelman WR Kurth JL Berdeaux RL 1997Brain Res Mol Brain Res1997,48,2:1
7A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors显示文摘SCHELMAN WR MORGAN-MEADOWS S MARNOCLtA R 2009Can Chemother Pharmacol2009,63,6:1
8First-in-human trial of a poly(ADP)-ribose polymerase(PARP)inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers(soc)显示文摘SCHELMAN WR SANDHU SK MORENO GARCIA V 2011J Clin Oncol2011,29,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费